期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 89, 期 5, 页码 746-749出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/clpt.2010.341
关键词
-
资金
- G. Harold and Leila Y. Mathers Charitable Foundation
- Sanofi-Aventis
- MICINN
- Fundacion Cellex
Pluripotent stem cells possess the capacity for self-renewal and the ability to differentiate into all cell types of the three embryonic germ layers. Accordingly, given their potential use in regenerative medicine, they have long attracted the attention of researchers. Embryonic stem cells (ESCs) represent the model pluripotent stem cell population. However, the use of ESCs in regenerative therapies faces major hurdles-namely, immune rejection and the necessity to use early-stage embryos for ESC isolation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据